Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for NATR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -3.456M
March 31, 2026 -1.579M
December 31, 2025 -2.363M
September 30, 2025 -2.395M
June 30, 2025 -12.12M
March 31, 2025 -0.731M
December 31, 2024 -0.576M
September 30, 2024 -1.018M
June 30, 2024 -8.418M
March 31, 2024 0.107M
December 31, 2023 -4.591M
September 30, 2023 -1.552M
June 30, 2023 -0.657M
March 31, 2023 -1.156M
December 31, 2022 -0.941M
September 30, 2022 -1.287M
June 30, 2022 -4.644M
March 31, 2022 -9.374M
December 31, 2021 -2.246M
September 30, 2021 -5.845M
June 30, 2021 -22.32M
March 31, 2021 -1.311M
December 31, 2020 -1.147M
September 30, 2020 -0.139M
June 30, 2020 5.323M
Date Value
March 31, 2020 -0.159M
December 31, 2019 0.07M
September 30, 2019 0.06M
June 30, 2019 -0.004M
March 31, 2019 -0.189M
December 31, 2018 -1.933M
September 30, 2018 -4.733M
June 30, 2018 -0.332M
March 31, 2018 -5.194M
December 31, 2017 -5.85M
September 30, 2017 7.682M
June 30, 2017 -1.202M
March 31, 2017 0.943M
December 31, 2016 -0.924M
September 30, 2016 3.28M
June 30, 2016 -5.495M
March 31, 2016 2.853M
December 31, 2015 -0.835M
September 30, 2015 -2.696M
June 30, 2015 -1.365M
March 31, 2015 -2.682M
December 31, 2014 -7.374M
September 30, 2014 7.02M
June 30, 2014 -3.875M
March 31, 2014 -0.847M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Cyanotech Corp. -0.08M
Mannatech, Inc. 0.228M
Natural Alternatives International, Inc. 4.04M
USANA Health Sciences, Inc. -14.03M
LifeVantage Corp. -1.15M